Zika/Lentiviral pseudotype particles as a novel tool for glioblastoma infection in oncolytic virotherapy

Zika/Lentiviral pseudotype particles as a novel tool for glioblastoma infection in oncolytic virotherapy

Bibliographic Details
Main Authors:	C. Schwalbe, M. Schreiber, P. Kremer
Format:	Article
Language:	English
Published:	Elsevier 2022-01-01
Series:	Brain and Spine
Online Access:	http://www.sciencedirect.com/science/article/pii/S2772529422006452

Similar Items

Zikavirus <i>pr</i>ME Envelope Pseudotyped Human Immunodeficiency Virus Type-1 as a Novel Tool for Glioblastoma-Directed Virotherapy
by: Maibritt Kretschmer, et al.
Published: (2020-04-01)

Development of Zika Virus E Variants for Pseudotyping Retroviral Vectors Targeting Glioblastoma Cells
by: Vivien Grunwald, et al.
Published: (2023-09-01)

Transduction Efficiency of Zika Virus E Protein Pseudotyped HIV-1<i>gfp</i> and Its Oncolytic Activity Tested in Primary Glioblastoma Cell Cultures
by: Jan Patrick Formanski, et al.
Published: (2024-02-01)

Glioblastoma microenvironment and its reprogramming by oncolytic virotherapy
by: Zhongbing Qi, et al.
Published: (2022-09-01)

Isolation of Cells from Glioblastoma Multiforme Grade 4 Tumors for Infection with Zika Virus prME and ME Pseudotyped HIV-1
by: Celine Pöhlking, et al.
Published: (2023-02-01)

Personalizing Oncolytic Virotherapy for Glioblastoma: In Search of Biomarkers for Response
by: Eftychia Stavrakaki, et al.
Published: (2021-02-01)

Current Status and Challenges of Oncolytic Virotherapy for the Treatment of Glioblastoma
by: Mason J. Webb, et al.
Published: (2023-05-01)

Oncolytic virotherapy
by: Daniel Cervantes-García;, et al.
Published: (2008-01-01)

Generation of Viral Particles with Brain Cell-Specific Tropism by Pseudotyping HIV-1 with the Zika Virus E Protein
by: Hai Dang Ngo, et al.
Published: (2023-12-01)

Combination of Oncolytic Virotherapy with Different Antitumor Approaches against Glioblastoma
by: Alisa Ageenko, et al.
Published: (2024-02-01)

Editorial: Oncolytic virotherapy
by: Ahmed Majeed Al-Shammari, et al.
Published: (2023-11-01)

Advances in oncolytic virotherapy
by: Stephen J. Russell, et al.
Published: (2022-04-01)

Effective Treatment of Glioblastoma Multiforme With Oncolytic Virotherapy: A Case-Series
by: Benjamin Gesundheit, et al.
Published: (2020-05-01)

Oncolytic virotherapy using neural stem cells as a novel treatment option for glioblastoma multiforme
by: Tanvir Ahmed
Published: (2023-03-01)

Mathematical modelling of oncolytic virotherapy
by: Shabala, A
Published: (2013)

Oncolytic Virotherapy in Glioma Tumors
by: Sergio Rius-Rocabert, et al.
Published: (2020-10-01)

Progress of oncolytic virotherapy for neuroblastoma
by: Xiao-Tong Chen, et al.
Published: (2022-11-01)

Syncytia Formation in Oncolytic Virotherapy
by: Chase Burton, et al.
Published: (2019-12-01)

Delivery and Biosafety of Oncolytic Virotherapy
by: Lizhi Li, et al.
Published: (2020-04-01)

ONCOLYTIC VIROTHERAPY IN GLIOBLASTOMA TREATMENT: PROGRESS AND CHALLENGES IN CLINICAL RESEARCH (LITERATURE REVIEW)
by: O. I. Kit, et al.
Published: (2020-12-01)

Investigating pseudotyped lentiviral vectors for gene delivery to the lung
by: Munday, RJ
Published: (2021)

Pseudotyping Lentiviral Vectors: When the Clothes Make the Virus
by: Alexis Duvergé, et al.
Published: (2020-11-01)

Oncolytic virotherapy – A novel strategy for cancer therapy
by: Mohanan Geetha Gopisankar, et al.
Published: (2018-07-01)

Tumor-Associated Macrophages/Microglia in Glioblastoma Oncolytic Virotherapy: A Double-Edged Sword
by: Sarah E. Blitz, et al.
Published: (2022-02-01)

Oncolytic Virotherapy and Microenvironment in Multiple Myeloma
by: Valentina Marchica, et al.
Published: (2021-02-01)

Oncolytic Virotherapy: The Cancer Cell Side
by: Marcelo Ehrlich, et al.
Published: (2021-02-01)

Oncolytic Virotherapy for Cancer: Clinical Experience
by: Shyambabu Chaurasiya, et al.
Published: (2021-04-01)

The Multifaceted Role of Macrophages in Oncolytic Virotherapy
by: Laura Hofman, et al.
Published: (2021-08-01)

The use of oncolytic virotherapy in the neoadjuvant setting
by: Eric Bartee, et al.
Published: (2022-04-01)

Oncolytic Virotherapy of Canine and Feline Cancer
by: Ivaylo Gentschev, et al.
Published: (2014-05-01)

Measles virus: Background and oncolytic virotherapy
by: Sankhajit Bhattacharjee, et al.
Published: (2018-03-01)

Multidisciplinary oncolytic virotherapy for gastrointestinal cancer
by: Toshiyoshi Fujiwara
Published: (2019-07-01)

Recent Advances in Oncolytic Virotherapy and Immunotherapy for Glioblastoma: A Glimmer of Hope in the Search for an Effective Therapy?
by: Aleksei A. Stepanenko, et al.
Published: (2018-12-01)

Protocol and Reagents for Pseudotyping Lentiviral Particles with SARS-CoV-2 Spike Protein for Neutralization Assays
by: Katharine H. D. Crawford, et al.
Published: (2020-05-01)

Cancer stem cell plasticity in glioblastoma multiforme: a perspective on future directions in oncolytic virotherapy
by: Kim, DS
Published: (2020)

Enhancing oncolytic virotherapy of glioblastoma by targeting innate immune ligands with a bispecific T cell engager
by: Baugh, R
Published: (2022)

Induction of broadly neutralising HCV antibodies in mice by integration-deficient lentiviral vector-based pseudotyped particles.
by: Yao Deng, et al.
Published: (2013-01-01)

Improved GaLV-TR Glycoproteins to Pseudotype Lentiviral Vectors: Impact of Viral Protease Activity in the Production of LV Pseudotypes
by: Hélio A. Tomás, et al.
Published: (2019-12-01)

Pseudotyped lentiviral vectors: Ready for translation into targeted cancer gene therapy?
by: Longfei Deng, et al.
Published: (2023-09-01)

Tumor Tropism of DNA Viruses for Oncolytic Virotherapy
by: Junior A. Enow, et al.
Published: (2023-11-01)